阿帕替尼治疗晚期胃癌对国家基本医疗保险支付预算的影响  

The effect of apatinib in the treatment of advanced gastric carcinoma on the budge of national basic medical insurance

作　　者：杨珍珍 韩晟[2] 王凯[1] 王淑梅[1] 史录文[2] YANG Zhen-zhen;HAN Sheng;WANG Kai;WANG Shu-mei;SHI Lu-wen(Department of Pharmacy,The Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;School of Pharmacy,Peking University Medi-cal Management International Research Ccenter,Beijing 100191,China)

机构地区：[1]河北医科大学第二医院药学部,石家庄050000 [2]北京大学医药管理国际研究中心,北京100191

出　　处：《临床药物治疗杂志》2020年第8期28-32,共5页Clinical Medication Journal

摘　　要：目的从医疗保险的角度,分析将阿帕替尼纳入《国家医保药品目录》(以下简称医保)后,对医保支付方预算的影响。方法通过构建预算影响分析模型,对目标人群、当前和未来可能的治疗方案组合以及药品费用进行估计,把情景一(阿帕替尼没有纳入医保)和情景二(阿帕替尼纳入医保)进行对比,分析未来5年(2018-2022年)总预算的变化。结果850 mg每日给药方案预算影响分析,情景二2018-2022年年医保基金用于晚期胃癌药品费用支出比情景一分别增加1401.88、1286.46、1160.42、1030.82和899.12万元;500 mg每日给药方案预算影响分析,情景二2018-2022年年医保基金用于晚期胃癌药品费用支出比情景一分别减少966.43、2030.20、3114.42、4211.03和5320.07万元。结论阿帕替尼850 mg每天给药方案治疗晚期肺癌纳入医保可能会带来医保总预算的增加,而500 mg每日给药方案纳入后可能会带来医保总预算的节约。Objective To analyze the impact of apatinib on the budget of national basic medical insurance after it is included in the National Medical Insurance Drug Catalog(hereinafter referred to as"medical insurance"),from the perspective of medical insurance.Methods A budge impact model was conducted to estimate the target population,the current and future combinations of treatment options,and the cost of medicines.Scenario 2(apatinib was listed in NRDL)was compared to scenario 1(apatinib was not listed in NRDL).The budget changes in the next five years(2018-2022)were analyzed.Results Based on the analysis of daily dose of 850 mg,compared to scenario 1,the expenditures of health insurance funds for scenario2 increased by 1401.88,1286.46,1160.42,1030.82,899.12 ten thousand yuan from 2018 to 2022,respectively.Based on the analysis of daily dose of 500 mg,compared to scenario 1,the expenditures of health insurance funds for scenario 2 were966.43,2030.20,3114.42,4211.03,5320.07 ten thousand yuan from 2018 to 2022,respectively.Conclusion apatinib of850 mg regimen may increase the total budget of basic medical insurance,and the 500 mg regimen may save the budget.

关 键 词：阿帕替尼 晚期胃癌 预算影响 

分 类 号：R979.1[医药卫生—药品] R956[医药卫生—药学]